N-BENZYL-2-PHENYLETHYLAMINE

CAS No. 3647-71-0

N-BENZYL-2-PHENYLETHYLAMINE( —— )

Catalog No. M22262 CAS No. 3647-71-0

N-BENZYL-2-PHENYLETHYLAMINE is an inhibitor of rel+ Escherichia coli B Phe-tRNA.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 177 In Stock
5MG 268 In Stock
10MG 408 In Stock
25MG 672 In Stock
50MG 945 In Stock
100MG 1278 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N-BENZYL-2-PHENYLETHYLAMINE
  • Note
    Research use only, not for human use.
  • Brief Description
    N-BENZYL-2-PHENYLETHYLAMINE is an inhibitor of rel+ Escherichia coli B Phe-tRNA.
  • Description
    N-BENZYL-2-PHENYLETHYLAMINE is an inhibitor of rel+ Escherichia coli B Phe-tRNA.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    rel+ Escherichia coli B Phe-tRNA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3647-71-0
  • Formula Weight
    211.3
  • Molecular Formula
    C15H17N
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(Cc1ccccc1)NCc2ccccc2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.R T Anderson Jr, D V Santi.Phenylalanyl transfer ribonucleic acid synthetase from Escherichia coli B. Potent inhibition by analogues of N-benzyl-2-phenylethylamine.J Med Chem. 1976 Nov;19(11):1270-5.
molnova catalog
related products
  • NS2(114 - 121), Infl...

    NS2(114 - 121), Influenza

  • LEM-14-1189 B

    Lem-14-1189, a LEM-14 derivative, is a potent NSD inhibitor of the nuclear receptor binding SET domain, and has inhibitory effects on NSD1, NSD2, and NSD3, with IC50 of 418 μM, 111 μM, and 60 μM, respectively.

  • Vaxfectin

    Vaxfectin is a lipid adjuvant used in the development of protein and peptide vaccines.Vaxfectin promotes vaccine immunogenicity.